Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Ultrasound-Guided Thoracolumbar Fascia Injection for Chronic Low Back Pain in Type 2 Diabetes

Official title: Efficacy of Ultrasound-Guided Thoracolumbar Fascia Injection in the Treatment of Chronic Low Back Pain in Patients With Type 2 Diabetes Mellitus: A Randomized Controlled Trial

Run by Kanuni Sultan Suleyman Training and Research Hospital · NCT07927530 · Data updated 2026-11-12

This trial tests whether an ultrasound-guided injection into the thoracolumbar fascia, added to standard care, helps reduce chronic low back pain in adults with type 2 diabetes.

More Chronic Low-back Pain trials

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment60 (estimated)
SponsorKanuni Sultan Suleyman Training and Research Hospital
Academic / other
Locations1 site (Küçükçekmece, Istanbul)
StatusRecruiting
StartedOctober 23, 2026
Main results expectedApril 30, 2027
Study endsApril 30, 2027
Registry record updatedNovember 10, 2026
Trial IDNCT07927530 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18-65 with type 2 diabetes for at least 1 year and chronic nonspecific low back pain lasting 3 months or more, with focal tenderness over the thoracolumbar fascia and baseline pain of at least 4/10.

Probably not a fit

Patients without thoracolumbar fascia tenderness or those with contraindications to injections may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, controlled trial will compare ultrasound-guided thoracolumbar fascia injections plus standard conservative treatment to standard conservative treatment alone in adults aged 18-65 with type 2 diabetes and chronic nonspecific low back pain. Participants will receive injections in addition to education and a structured exercise program, with assessments at baseline, 1 month, and 3 months measuring pain intensity and other outcomes. The study aims to determine if adding the injection provides greater pain relief than standard care alone. Enrollment targets 60 participants across a single center in Istanbul, Turkey. The lead sponsor is Hatice Zehra Ferhatlar, with no listed collaborators.

Why it matters

Potential benefit: If successful, patients may experience greater reductions in back pain and improved function when adding the injection to standard care.

How similar studies have gone: Prior research has explored fascia injections for back pain, but this specific diabetes-related, ultrasound-guided thoracolumbar fascia approach is novel in this population.

Who can join: the full rules

Show full inclusion / exclusion criteria
\*\*Inclusion Criteria:\*\*

* Age between 18 and 65 years.
* Diagnosis of type 2 diabetes mellitus for at least 1 year.
* Chronic low back pain lasting at least 3 months.
* Nonspecific or mechanical low back pain.
* Baseline pain intensity of ≥4 on the Numeric Rating Scale (NRS).
* Pain or tenderness on palpation over the thoracolumbar fascia region.
* Willingness to participate in the study.
* Provision of written informed consent.

\*\*Exclusion Criteria:\*\*

* Radiculopathy or significant neurological deficits.
* Neurogenic claudication due to spinal stenosis.
* Spinal tumor or infection.
* History or presence of vertebral fracture.
* Inflammatory rheumatic disease.
* Spinal surgery within the previous 6 months.
* Injection in the lumbar region within the previous 3 months.
* Anticoagulant therapy or conditions contraindicating injection.
* Active infection at the injection site.
* Severe systemic disease, including advanced renal failure.
* Uncontrolled diabetic metabolic condition.
* Pregnancy.

Where it's running

  • Kanuni Sultan Suleyman Training and Research Hospital
    Küçükçekmece, Istanbul, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.